{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T18:38:08Z","timestamp":1788028688068,"version":"build-2784847793"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Youth Foundation of Chinese PLA General Hospital","award":["QNF19065"],"award-info":[{"award-number":["QNF19065"]}]},{"DOI":"10.13039\/501100002858","name":"Chinese Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2020M673676"],"award-info":[{"award-number":["2020M673676"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["Z181100006218001"],"award-info":[{"award-number":["Z181100006218001"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science & Technology Major Project \u201cKey New Drug Creation and Manufacturing Program\u201d","award":["2018ZX09101002-001-002"],"award-info":[{"award-number":["2018ZX09101002-001-002"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81630100"],"award-info":[{"award-number":["81630100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine","award":["ZYYCXTD-C-202005"],"award-info":[{"award-number":["ZYYCXTD-C-202005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiosyncratic drug-induced liver injury (IDILI) is common in hepatology practices and, in some cases, lethal. Increasing evidence show that tricyclic antidepressants (TCAs) can induce IDILI in clinical applications but the underlying mechanisms are still poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We assessed the specificity of several TCAs for NLRP3 inflammasome via MCC950 (a selective NLRP3 inhibitor) pretreatment and\n                      <jats:italic>Nlrp3<\/jats:italic>\n                      knockout (\n                      <jats:italic>Nlrp3<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      ) BMDMs. Meanwhile, the role of NLRP3 inflammasome in the TCA nortriptyline-induced hepatotoxicity was demonstrated in\n                      <jats:italic>Nlrp3<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We reported here that nortriptyline, a common TCA, induced idiosyncratic hepatotoxicity in a NLRP3 inflammasome-dependent manner in mildly inflammatory states. In parallel in vitro studies, nortriptyline triggered the inflammasome activation, which was completely blocked by\n                      <jats:italic>Nlrp3<\/jats:italic>\n                      deficiency or MCC950 pretreatment. Furthermore, nortriptyline treatment led to mitochondrial damage and subsequent mitochondrial reactive oxygen species (mtROS) production resulting in aberrant activation of the NLRP3 inflammasome; a selective mitochondrial ROS inhibitor pretreatment dramatically abrogated nortriptyline-triggered the NLRP3 inflammasome activation. Notably, exposure to other TCAs also induced aberrant activation of the NLRP3 inflammasome by triggering upstream signaling events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Collectively, our findings revealed that the NLRP3 inflammasome may act as a crucial target for TCA agents and suggested that the core structures of TCAs may contribute to\u00a0the aberrant activation of NLRP3 inflammasome induced by them, an important factor involved in the pathogenesis of TCA-induced liver injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-023-01128-x","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T08:02:00Z","timestamp":1685001720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation"],"prefix":"10.1186","volume":"21","author":[{"given":"Wenqing","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"1128_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s40263-018-0537-1","volume":"32","author":"S Billioti de Gage","year":"2018","unstructured":"Billioti de Gage S, Collin C, Le-Tri T, Pariente A, B\u00e9gaud B, Verdoux H, Dray-Spira R, Zureik M. Antidepressants and Hepatotoxicity: a Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database. CNS Drugs. 2018;32:673\u201384.","journal-title":"CNS Drugs"},{"key":"1128_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1176\/appi.ajp.2013.13050709","volume":"171","author":"CS Voican","year":"2014","unstructured":"Voican CS, Corruble E, Naveau S, Perlemuter G. Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry. 2014;171:404\u201315.","journal-title":"Am J Psychiatry"},{"key":"1128_CR3","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/hep.510290535","volume":"29","author":"K Selim","year":"1999","unstructured":"Selim K, Kaplowitz N. Hepatotoxicity of psychotropic drugs. Hepatology. 1999;29:1347\u201351.","journal-title":"Hepatology"},{"key":"1128_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4088\/JCP.v63n0208","volume":"63","author":"A Carvajal Garc\u00eda-Pando","year":"2002","unstructured":"Carvajal Garc\u00eda-Pando A, Garc\u00eda del Pozo J, S\u00e1nchez AS, Velasco MA, Rueda de Castro AM, Lucena MI. Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry. 2002;63:135\u20137.","journal-title":"J Clin Psychiatry"},{"key":"1128_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1192\/bjp.115.518.105","volume":"115","author":"DH Morgan","year":"1969","unstructured":"Morgan DH. Jaundice associated with amitriptyline. Br J Psychiatry. 1969;115:105\u20136.","journal-title":"Br J Psychiatry"},{"key":"1128_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0168-8278(86)80011-3","volume":"2","author":"D Larrey","year":"1986","unstructured":"Larrey D, Pessayre D, Duhamel G, Casier A, Degott C, Feldmann G, Erlinger S, Benhamou JP. Prolonged cholestasis after ajmaline-induced acute hepatitis. J Hepatol. 1986;2:81\u20137.","journal-title":"J Hepatol"},{"key":"1128_CR7","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/gut.27.6.726","volume":"27","author":"D Larrey","year":"1986","unstructured":"Larrey D, Rueff B, Pessayre D, Danan G, Algard M, Geneve J, Benhamou JP. Cross hepatotoxicity between tricyclic antidepressants. Gut. 1986;27:726\u20137.","journal-title":"Gut"},{"key":"1128_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s002040050599","volume":"73","author":"Y Masubuchi","year":"1999","unstructured":"Masubuchi Y, Konishi M, Horie T. Imipramine- and mianserin-induced acute cell injury in primary cultured rat hepatocytes: implication of different cytochrome P450 enzymes. Arch Toxicol. 1999;73:147\u201351.","journal-title":"Arch Toxicol"},{"key":"1128_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd1750","volume":"4","author":"N Kaplowitz","year":"2005","unstructured":"Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 2005;4:489\u201399.","journal-title":"Nat Rev Drug Discov"},{"key":"1128_CR10","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1345\/aph.1K114","volume":"41","author":"KP DeSanty","year":"2007","unstructured":"DeSanty KP, Amabile CM. Antidepressant-induced liver injury. Ann Pharmacother. 2007;41:1201\u201311.","journal-title":"Ann Pharmacother"},{"key":"1128_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0041-008X(79)90070-X","volume":"47","author":"H Yasuhara","year":"1979","unstructured":"Yasuhara H, Dujovne CA, Ueda I, Arakawa K. Hepatotoxicity and surface activity of tricyclic antidepressants in vitro. Toxicol Appl Pharmacol. 1979;47:47\u201354.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1128_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00007691-199602000-00017","volume":"18","author":"AM Pedersen","year":"1996","unstructured":"Pedersen AM, Enevoldsen HK. Nortriptyline-induced hepatic failure. Ther Drug Monit. 1996;18:100\u20132.","journal-title":"Ther Drug Monit"},{"key":"1128_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/00004836-199501000-00014","volume":"20","author":"C Berkelhammer","year":"1995","unstructured":"Berkelhammer C, Kher N, Berry C, Largosa A. Nortriptyline-induced fulminant hepatic failure. J Clin Gastroenterol. 1995;20:54\u20136.","journal-title":"J Clin Gastroenterol"},{"key":"1128_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12608","volume":"281","author":"MM Hughes","year":"2018","unstructured":"Hughes MM, O\u2019Neill LAJ. Metabolic regulation of NLRP3. Immunol Rev. 2018;281:88\u201398.","journal-title":"Immunol Rev"},{"key":"1128_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13:148\u201359.","journal-title":"Cell Mol Immunol"},{"key":"1128_CR16","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int J Mol Sci. 2019;20:3328.","journal-title":"Int J Mol Sci"},{"key":"1128_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki N, Stowe IB, Lee BL, O\u2019Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526:666\u201371.","journal-title":"Nature"},{"key":"1128_CR18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2009.02.006","volume":"30","author":"PG Thomas","year":"2009","unstructured":"Thomas PG, Dash P, Aldridge JR Jr, Ellebedy AH, Reynolds C, Funk AJ, Martin WJ, Lamkanfi M, Webby RJ, Boyd KL, et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity. 2009;30:566\u201375.","journal-title":"Immunity"},{"key":"1128_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature07965","volume":"459","author":"O Gross","year":"2009","unstructured":"Gross O, Poeck H, Bscheider M, Dostert C, Hannesschl\u00e4ger N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature. 2009;459:433\u20136.","journal-title":"Nature"},{"key":"1128_CR20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41564-019-0371-3","volume":"4","author":"M Ahn","year":"2019","unstructured":"Ahn M, Anderson DE, Zhang Q, Tan CW, Lim BL, Luko K, Wen M, Chia WN, Mani S, Wang LC, et al. Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host. Nat Microbiol. 2019;4:789\u201399.","journal-title":"Nat Microbiol"},{"key":"1128_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10875-019-00638-z","volume":"39","author":"LM Booshehri","year":"2019","unstructured":"Booshehri LM, Hoffman HM. CAPS and NLRP3. J Clin Immunol. 2019;39:277\u201386.","journal-title":"J Clin Immunol"},{"key":"1128_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"N Dalbeth","year":"2019","unstructured":"Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, Stamp LK. Gout. Nat Rev Dis Primers. 2019;5:69.","journal-title":"Nat Rev Dis Primers"},{"key":"1128_CR23","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","volume":"122","author":"A Grebe","year":"2018","unstructured":"Grebe A, Hoss F, Latz E. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circ Res. 2018;122:1722\u201340.","journal-title":"Circ Res"},{"key":"1128_CR24","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3390\/cells8121595","volume":"8","author":"NS Ferreira","year":"2019","unstructured":"Ferreira NS, Bruder-Nascimento T, Pereira CA, Zanotto CZ, Prado DS, Silva JF, Rassi DM, Foss-Freitas MC, Alves-Filho JC, Carlos D, Tostes RC. NLRP3 Inflammasome and mineralocorticoid receptors are associated with vascular dysfunction in type 2 diabetes mellitus. Cells. 2019;8:1595.","journal-title":"Cells"},{"key":"1128_CR25","doi-asserted-by":"publisher","first-page":"105388","DOI":"10.1016\/j.phrs.2020.105388","volume":"164","author":"J Zou","year":"2021","unstructured":"Zou J, Wang SP, Wang YT, Wan JB. Regulation of the NLRP3 inflammasome with natural products against chemical-induced liver injury. Pharmacol Res. 2021;164:105388.","journal-title":"Pharmacol Res"},{"key":"1128_CR26","doi-asserted-by":"publisher","first-page":"9141","DOI":"10.1039\/C8NR00554K","volume":"10","author":"X Zhang","year":"2018","unstructured":"Zhang X, Luan J, Chen W, Fan J, Nan Y, Wang Y, Liang Y, Meng G, Ju D. Mesoporous silica nanoparticles induced hepatotoxicity via NLRP3 inflammasome activation and caspase-1-dependent pyroptosis. Nanoscale. 2018;10:9141\u201352.","journal-title":"Nanoscale"},{"key":"1128_CR27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.apsb.2019.02.003","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang Z, Xu G, Gao Y, Zhan X, Qin N, Fu S, Li R, Niu M, Wang J, Liu Y, et al. Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome. Acta Pharm Sin B. 2019;9:734\u201344.","journal-title":"Acta Pharm Sin B"},{"key":"1128_CR28","doi-asserted-by":"publisher","first-page":"8086253","DOI":"10.1155\/2021\/8086253","volume":"2021","author":"Q Su","year":"2021","unstructured":"Su Q, Kuang W, Hao W, Liang J, Wu L, Tang C, Wang Y, Liu T. Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes. Mediators Inflamm. 2021;2021:8086253.","journal-title":"Mediators Inflamm"},{"key":"1128_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1517\/14740338.2.3.249","volume":"2","author":"MI Lucena","year":"2003","unstructured":"Lucena MI, Carvajal A, Andrade RJ, Velasco A. Antidepressant-induced hepatotoxicity. Expert Opin Drug Saf. 2003;2:249\u201362.","journal-title":"Expert Opin Drug Saf"},{"key":"1128_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2017.03.004","volume":"447","author":"M O'Brien","year":"2017","unstructured":"O\u2019Brien M, Moehring D, Mu\u00f1oz-Planillo R, N\u00fa\u00f1ez G, Callaway J, Ting J, Scurria M, Ugo T, Bernad L, Cali J, Lazar D. A bioluminescent caspase-1 activity assay rapidly monitors inflammasome activation in cells. J Immunol Methods. 2017;447:1\u201313.","journal-title":"J Immunol Methods"},{"key":"1128_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41419-020-2460-x","volume":"11","author":"W Shi","year":"2020","unstructured":"Shi W, Xu G, Zhan X, Gao Y, Wang Z, Fu S, Qin N, Hou X, Ai Y, Wang C, et al. Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases. Cell Death Dis. 2020;11:252.","journal-title":"Cell Death Dis"},{"key":"1128_CR32","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.apsb.2020.03.006","volume":"10","author":"Z Wang","year":"2020","unstructured":"Wang Z, Xu G, Wang H, Zhan X, Gao Y, Chen N, Li R, Song X, Guo Y, Yang R, et al. Icariside II, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation. Acta Pharm Sin B. 2020;10:1619\u201333.","journal-title":"Acta Pharm Sin B"},{"key":"1128_CR33","doi-asserted-by":"publisher","first-page":"105384","DOI":"10.1016\/j.phrs.2020.105384","volume":"164","author":"H Liu","year":"2021","unstructured":"Liu H, Zhan X, Xu G, Wang Z, Li R, Wang Y, Qin Q, Shi W, Hou X, Yang R, et al. Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases. Pharmacol Res. 2021;164:105384.","journal-title":"Pharmacol Res"},{"key":"1128_CR34","doi-asserted-by":"publisher","first-page":"e134601","DOI":"10.1172\/jci.insight.134601","volume":"6","author":"G Xu","year":"2021","unstructured":"Xu G, Fu S, Zhan X, Wang Z, Zhang P, Shi W, Qin N, Chen Y, Wang C, Niu M, et al. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI Insight. 2021;6.","journal-title":"JCI Insight"},{"key":"1128_CR35","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.celrep.2018.07.098","volume":"24","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Rong H, Zhang FX, Wu K, Mu L, Meng J, Xiao B, Zamponi GW, Shi Y. A Membrane Potential- and Calpain-Dependent Reversal of Caspase-1 Inhibition Regulates Canonical NLRP3 Inflammasome. Cell Rep. 2018;24:2356-2369.e2355.","journal-title":"Cell Rep"},{"key":"1128_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jsb.2017.08.001","volume":"200","author":"B Wang","year":"2017","unstructured":"Wang B, Yin Q. AIM2 inflammasome activation and regulation: A structural perspective. J Struct Biol. 2017;200:279\u201382.","journal-title":"J Struct Biol"},{"key":"1128_CR37","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3390\/ijms22031048","volume":"22","author":"B Sundaram","year":"2021","unstructured":"Sundaram B, Kanneganti TD. Advances in Understanding Activation and Function of the NLRC4 Inflammasome. Int J Mol Sci. 2021;22:1048.","journal-title":"Int J Mol Sci"},{"key":"1128_CR38","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, Chitty JL, Fraser JA, Jennings MP, Robertson AAB, Schroder K. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15:556\u20139.","journal-title":"Nat Chem Biol"},{"key":"1128_CR39","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.4049\/jimmunol.1300530","volume":"191","author":"JJ Kaminski","year":"2013","unstructured":"Kaminski JJ, Schattgen SA, Tzeng TC, Bode C, Klinman DM, Fitzgerald KA. Synthetic oligodeoxynucleotides containing suppressive TTAGGG motifs inhibit AIM2 inflammasome activation. J Immunol. 2013;191:3876\u201383.","journal-title":"J Immunol"},{"key":"1128_CR40","doi-asserted-by":"publisher","first-page":"17935","DOI":"10.1038\/srep17935","volume":"5","author":"SX Yu","year":"2015","unstructured":"Yu SX, Du CT, Chen W, Lei QQ, Li N, Qi S, Zhang XJ, Hu GQ, Deng XM, Han WY, Yang YJ. Genipin inhibits NLRP3 and NLRC4 inflammasome activation via autophagy suppression. Sci Rep. 2015;5:17935.","journal-title":"Sci Rep"},{"key":"1128_CR41","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.1117765109","volume":"109","author":"T Murakami","year":"2012","unstructured":"Murakami T, Ockinger J, Yu J, Byles V, McColl A, Hofer AM, Horng T. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A. 2012;109:11282\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1128_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature11588","volume":"492","author":"GS Lee","year":"2012","unstructured":"Lee GS, Subramanian N, Kim AI, Aksentijevich I, Goldbach-Mansky R, Sacks DB, Germain RN, Kastner DL, Chae JJ. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature. 2012;492:123\u20137.","journal-title":"Nature"},{"key":"1128_CR43","doi-asserted-by":"publisher","first-page":"609441","DOI":"10.3389\/fimmu.2020.609441","volume":"11","author":"Z Xu","year":"2020","unstructured":"Xu Z, Chen ZM, Wu X, Zhang L, Cao Y, Zhou P. Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation. Front Immunol. 2020;11:609441.","journal-title":"Front Immunol"},{"key":"1128_CR44","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","volume":"560","author":"Z Zhong","year":"2018","unstructured":"Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin XJ, Wong J, Ding S, Seki E, Schnabl B, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 2018;560:198\u2013203.","journal-title":"Nature"},{"key":"1128_CR45","doi-asserted-by":"publisher","first-page":"8639618","DOI":"10.1155\/2019\/8639618","volume":"2019","author":"JS Ye","year":"2019","unstructured":"Ye JS, Chen L, Lu YY, Lei SQ, Peng M, Xia ZY. Honokiol-Mediated Mitophagy Ameliorates Postoperative Cognitive Impairment Induced by Surgery\/Sevoflurane via Inhibiting the Activation of NLRP3 Inflammasome in the Hippocampus. Oxid Med Cell Longev. 2019;2019:8639618.","journal-title":"Oxid Med Cell Longev"},{"key":"1128_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ana.24070","volume":"75","author":"Q Ma","year":"2014","unstructured":"Ma Q, Chen S, Hu Q, Feng H, Zhang JH, Tang J. NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage. Ann Neurol. 2014;75:209\u201319.","journal-title":"Ann Neurol"},{"key":"1128_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41423-019-0260-y","volume":"17","author":"X He","year":"2020","unstructured":"He X, Yang W, Zeng Z, Wei Y, Gao J, Zhang B, Li L, Liu L, Wan Y, Zeng Q, et al. NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology. Cell Mol Immunol. 2020;17:283\u201399.","journal-title":"Cell Mol Immunol"},{"key":"1128_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41419-017-0257-3","volume":"9","author":"X Wu","year":"2018","unstructured":"Wu X, Zhang H, Qi W, Zhang Y, Li J, Li Z, Lin Y, Bai X, Liu X, Chen X, et al. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis. 2018;9:171.","journal-title":"Cell Death Dis"},{"key":"1128_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/taap.2000.8968","volume":"166","author":"SB Yee","year":"2000","unstructured":"Yee SB, Kinser S, Hill DA, Barton CC, Hotchkiss JA, Harkema JR, Ganey PE, Roth RA. Synergistic hepatotoxicity from coexposure to bacterial endotoxin and the pyrrolizidine alkaloid monocrotaline. Toxicol Appl Pharmacol. 2000;166:173\u201385.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1128_CR50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/toxsci\/kfn205","volume":"107","author":"PJ Shaw","year":"2009","unstructured":"Shaw PJ, Ditewig AC, Waring JF, Liguori MJ, Blomme EA, Ganey PE, Roth RA. Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury. Toxicol Sci. 2009;107:270\u201380.","journal-title":"Toxicol Sci"},{"key":"1128_CR51","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/hep.20492","volume":"40","author":"JP Luyendyk","year":"2004","unstructured":"Luyendyk JP, Maddox JF, Green CD, Ganey PE, Roth RA. Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats. Hepatology. 2004;40:1342\u201351.","journal-title":"Hepatology"},{"key":"1128_CR52","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0016-5085(88)90631-2","volume":"94","author":"D Larrey","year":"1988","unstructured":"Larrey D, Amouyal G, Pessayre D, Degott C, Danne O, Machayekhi JP, Feldmann G, Benhamou JP. Amitriptyline-induced prolonged cholestasis. Gastroenterology. 1988;94:200\u20133.","journal-title":"Gastroenterology"},{"key":"1128_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0016-5085(60)80121-7","volume":"38","author":"G Herron","year":"1960","unstructured":"Herron G, Bourdo S. Jaundice secondary to promazine, and an analysis of possible cross sensitivities between phenothiazine derivatives. Gastroenterology. 1960;38:87\u201390.","journal-title":"Gastroenterology"},{"key":"1128_CR54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0168-8278(94)80237-8","volume":"21","author":"Y Le Bricquir","year":"1994","unstructured":"Le Bricquir Y, Larrey D, Blanc P, Pageaux GP, Michel H. Tianeptine\u2013an instance of drug-induced hepatotoxicity predicted by prospective experimental studies. J Hepatol. 1994;21:771\u20133.","journal-title":"J Hepatol"},{"key":"1128_CR55","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen GY, Nu\u00f1ez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10:826\u201337.","journal-title":"Nat Rev Immunol"},{"key":"1128_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong T, Liu L, Jiang W, Zhou R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020;20:95\u2013112.","journal-title":"Nat Rev Immunol"},{"key":"1128_CR57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237\u201341.","journal-title":"Nature"},{"key":"1128_CR58","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"C Dostert","year":"2008","unstructured":"Dostert C, P\u00e9trilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320:674\u20137.","journal-title":"Science"},{"key":"1128_CR59","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.1038\/cddis.2012.144","volume":"3","author":"N Riteau","year":"2012","unstructured":"Riteau N, Baron L, Villeret B, Guillou N, Savigny F, Ryffel B, Rassendren F, Le Bert M, Gombault A, Couillin I. ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation. Cell Death Dis. 2012;3:e403.","journal-title":"Cell Death Dis"},{"key":"1128_CR60","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nu\u00f1ez G, Schnurr M, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357\u201361.","journal-title":"Nature"},{"key":"1128_CR61","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol. 2011;12:408\u201315.","journal-title":"Nat Immunol"},{"key":"1128_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","volume":"595","author":"KO Dixon","year":"2021","unstructured":"Dixon KO, Tabaka M, Schramm MA, Xiao S, Tang R, Dionne D, Anderson AC, Rozenblatt-Rosen O, Regev A, Kuchroo VK. TIM-3 restrains anti-tumour immunity by regulating inflammasome activation. Nature. 2021;595:101\u20136.","journal-title":"Nature"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01128-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-023-01128-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01128-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T08:04:57Z","timestamp":1685001897000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-023-01128-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1186\/s12964-023-01128-x","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"4 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the experimental protocols have been approved by the Animal Ethics Committee of the Fifth Medical Center, Chinese People's Liberation Army (PLA) General Hospital (Beijing, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}